PARADISE Trademark

Trademark Overview


On Thursday, January 14, 2021, a trademark application was filed for PARADISE with the United States Patent and Trademark Office. The USPTO has given the PARADISE trademark a serial number of 90465900. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, May 2, 2024. This trademark is owned by ReCor Medical, Inc.. The PARADISE trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical device systems consisting of medical devices for treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; medical devices for treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical device systems for use in renal denervation and other forms of neuromodulation of the autonomic nervous system, consisting of glass cartridges for medical fluids, carts, guiding catheters, medical guidewires, medical introducers, and remo...
paradise

General Information


Serial Number90465900
Word MarkPARADISE
Filing DateThursday, January 14, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, May 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Goods and ServicesMedical apparatus and instruments for treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical device systems consisting of medical devices for treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; medical devices for treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical device systems for use in renal denervation and other forms of neuromodulation of the autonomic nervous system, consisting of glass cartridges for medical fluids, carts, guiding catheters, medical guidewires, medical introducers, and remote controls for medical devices for use in performing denervation of human beings; energy emitting catheter-based systems consisting of medical devices and devices for medical procedures in the nature of neuromodulation and denervation of the autonomic nervous system for use in treating a variety of medical conditions, including arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety, contrast nephropathy, diabetes, metabolic disorder and insulin resistance, among other medical conditions and also consisting of glass cartridges for medical fluids, carts, guiding catheters, medical guidewires, medical introducers, and remote controls for medical devices used in connection with the preceding systems and devices; medical devices for sensing nerve activity and for performing denervation; guiding catheters

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, April 14, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReCor Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303

Party NameReCor Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303

Trademark Events


Event DateEvent Description
Monday, January 18, 2021NEW APPLICATION ENTERED
Wednesday, April 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 26, 2021ASSIGNED TO EXAMINER
Wednesday, July 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 28, 2021NON-FINAL ACTION WRITTEN
Wednesday, July 28, 2021NON-FINAL ACTION E-MAILED
Wednesday, July 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 1, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 1, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, February 1, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 1, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, February 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 3, 2022SOU EXTENSION 1 FILED
Thursday, November 3, 2022SOU EXTENSION 1 GRANTED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 3, 2023DIVISIONAL REQUEST RECEIVED
Thursday, April 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 6, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, April 6, 2023SOU EXTENSION 2 FILED
Wednesday, April 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 26, 2023DIVISIONAL PROCESSING COMPLETE
Wednesday, April 26, 2023SOU EXTENSION 2 GRANTED
Thursday, April 27, 2023CORRECTED NOA E-MAILED
Thursday, April 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU EXTENSION 4 FILED
Thursday, November 2, 2023SOU EXTENSION 3 FILED
Thursday, November 2, 2023SOU EXTENSION 3 GRANTED
Saturday, November 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 2, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU EXTENSION 4 GRANTED
Friday, May 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2024SOU TEAS EXTENSION RECEIVED
Friday, November 1, 2024TEAS STATEMENT OF USE RECEIVED